|
Volumn 4, Issue 3, 2002, Pages 184-190
|
Cardiovascular effects of novel antipsychotic medications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
ZIPRASIDONE;
ZYPREXIA;
CARDIOVASCULAR AGENT;
PIRENZEPINE;
ATRIOVENTRICULAR BLOCK;
BRADYCARDIA;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR EFFECT;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CORONARY ARTERY DISEASE;
DEEP VEIN THROMBOSIS;
HEART PALPITATION;
HEART VENTRICLE EXTRASYSTOLE;
HUMAN;
HYPERTENSION;
LUNG EMBOLISM;
MEDLINE;
ORTHOSTATIC HYPOTENSION;
PSYCHOPHARMACOLOGY;
PSYCINFO;
REVIEW;
TACHYCARDIA;
DRUG INTERACTION;
FEMALE;
FOLLOW UP;
MALE;
RISK ASSESSMENT;
SURVIVAL;
ANTIPSYCHOTIC AGENTS;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
CLOZAPINE;
DRUG INTERACTIONS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
PIRENZEPINE;
RISK ASSESSMENT;
RISPERIDONE;
SURVIVAL ANALYSIS;
|
EID: 0036087581
PISSN: 1521737X
EISSN: None
Source Type: Journal
DOI: 10.1097/00132580-200205000-00009 Document Type: Review |
Times cited : (23)
|
References (34)
|